Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19.
COVID-19
cancer
influenza
vaccination
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
received:
28
03
2021
revised:
12
04
2021
accepted:
18
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Recently developed COVID-19 vaccines significantly reduce the risk of severe coronavirus disease, which is essential in the particularly vulnerable cancer patient population. There is a growing anti-vaccine concern that may affect the success of the fight against the SARS-CoV2 pandemic. To evaluate opinions and attitudes toward vaccination, we conducted an anonymous online survey among Polish patients diagnosed with cancer. We analyzed how socio-demographic factors, type of cancer, comorbidities, previous influenza vaccinations, and information sources affect the general willingness and opinions about vaccinations, emphasizing vaccination against COVID-19. Six hundred thirty-five patients (80.2% female) participated in the study. A positive attitude towards vaccination was presented by 73.7%, neutral by 17.8%, while negative by 8.5%. Willingness to get vaccinated was declared by 60.3%, 23.5% were unwilling, and 16.2% were undecided. Significant predictors of willingness were education, marital status, active anti-cancer treatment, previous influenza vaccination, and positive attitude towards vaccinations. Patients with cancer have concerns regarding safety, effectiveness, and the process of development of the COVID-19 vaccine. Overall, patients with cancer present positive attitudes towards COVID-19 vaccination but required sufficient information on its efficacy and side effects.
Identifiants
pubmed: 33919048
pii: vaccines9050411
doi: 10.3390/vaccines9050411
pmc: PMC8142983
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Oncol. 2017 Feb 1;28(2):400-407
pubmed: 27831506
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Clin Infect Dis. 2020 Jul 28;71(15):703-705
pubmed: 32282038
Psychiatry Res. 2020 Dec;294:113540
pubmed: 33142144
ESMO Open. 2020 Oct;5(5):e000970
pubmed: 33097653
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
Vaccine. 2015 Mar 30;33(14):1682-7
pubmed: 25720791
Clin Microbiol Infect. 2014 Sep;20(9):899-905
pubmed: 24655107
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Healthcare (Basel). 2021 Mar 19;9(3):
pubmed: 33808758
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Infect Control Hosp Epidemiol. 2015 Oct;36(10):1239-41
pubmed: 26132392
Vaccine. 2017 Oct 27;35(45):6059-6069
pubmed: 28974409
J BUON. 2013 Apr-Jun;18(2):511-5
pubmed: 23818370
J Family Med Prim Care. 2020 Sep 30;9(9):4904-4910
pubmed: 33209820
Eur J Cancer. 2020 Nov;139:43-50
pubmed: 32971510
Ann Oncol. 2021 Jun;32(6):787-800
pubmed: 33746047
Eur J Cancer. 2017 May;76:134-143
pubmed: 28324748
Ann Oncol. 2008 Sep;19(9):1658
pubmed: 18662953
Cancer Discov. 2021 Feb;11(2):233-236
pubmed: 33355178
Ann Oncol. 2021 May;32(5):673-674
pubmed: 33529740
Ann Oncol. 2021 May;32(5):579-581
pubmed: 33582237
Psychol Med. 2020 May 21;:1-13
pubmed: 32436485
Nat Rev Clin Oncol. 2021 May;18(5):313-319
pubmed: 33723371
Am J Med. 2021 Feb;134(2):176-181
pubmed: 32979306
Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21-5
pubmed: 16200144
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
Ann Oncol. 2021 Jan;32(1):113-119
pubmed: 33098994
Mayo Clin Proc. 2015 Nov;90(11):1562-8
pubmed: 26541249
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433
pubmed: 24821919
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246